(Q54442273)
Statements
Phase II trial of medroxyprogesterone acetate in advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group Study. (English)
Hamerlynck JV
Maskens AP
Mangioni C
van der Burg ME
Wils JA
Vermorken JB
Rotmensz N
1 November 1985
22
3
313-316